Artemisia annua decaffeinated coffee
Term · Oncology and biomedicine · MLC-T-ONC-011236
A decaffeinated coffee formulation containing Artemisia annua, with potential anti-inflammatory, antioxidant and chemopreventive activities. Artemisia annua contains specific sesquiterpene lactones, flavonoids, coumarins, phenolic acids, tannins, saponins, polyalkenes, phytosterols, fatty acids and proteins. The antioxidant compounds scavenge free radicals and inhibit cell damage due to reactive oxygen species (ROS). This inhibits oxidative stress and may protect against DNA damage.
| Identifier | MLC-T-ONC-011236 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Aa decaffeinated coffee; ArtemiCoffee; Artemisia annua-blended decaffeinated coffee; A. annua decaffeinated coffee |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011236",
"term": "Artemisia annua decaffeinated coffee",
"field": "Oncology and biomedicine",
"definition": "A decaffeinated coffee formulation containing Artemisia annua, with potential anti-inflammatory, antioxidant and chemopreventive activities. Artemisia annua contains specific sesquiterpene lactones, flavonoids, coumarins, phenolic acids, tannins, saponins, polyalkenes, phytosterols, fatty acids and proteins. The antioxidant compounds scavenge free radicals and inhibit cell damage due to reactive oxygen species (ROS). This inhibits oxidative stress and may protect against DNA damage.",
"synonyms": [
"Aa decaffeinated coffee",
"ArtemiCoffee",
"Artemisia annua-blended decaffeinated coffee",
"A. annua decaffeinated coffee"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/artemisia-annua-decaffeinated-coffee/"
}
Record 2,455 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.